Over time, most people do experience noticeable appetite suppression, which supports long-term weight loss and better blood sugar control
Contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
It is a GLP-1 receptor agonist that helps control blood sugar levels, suppresses appetite, and may aid in weight reduction
Broader adverse event profiles have been synthesized in meta-analyses, supporting the need for careful surveillance and individualized risk-benefit assessment rather than categorical assumptions of safety or harm [34]
This means that it stimulates insulin release only when blood sugar levels are elevated, thereby reducing the risk of hypoglycemia, a common concern with other diabetes medications
Liu MJ, Bao S, Galvez-Peralta M, Pyle CJ, Rudawsky AC, Pavlovicz RE, et al